Biological Agents in the Treatment of Crohn's Disease: A Propensity Score-Matched Analysis From the Prospective Persistence Australian National IBD Cohort (PANIC3) Study.

MLA

Chetwood, John David, et al. “Biological Agents in the Treatment of Crohn’s Disease: A Propensity Score-Matched Analysis From the Prospective Persistence Australian National IBD Cohort (PANIC3) Study.” American Journal of Gastroenterology (Lippincott Williams & Wilkins), vol. 119, no. 8, Aug. 2024, pp. 1536–44. EBSCOhost, https://doi.org/10.14309/ajg.0000000000002679.

APA

Chetwood, J. D., Ko, Y., Pudipeddi, A., Kariyawasam, V., Paramsothy, S., & Leong, R. W. (2024). Biological Agents in the Treatment of Crohn’s Disease: A Propensity Score-Matched Analysis From the Prospective Persistence Australian National IBD Cohort (PANIC3) Study. American Journal of Gastroenterology (Lippincott Williams & Wilkins), 119(8), 1536–1544. https://doi.org/10.14309/ajg.0000000000002679

Chicago

Chetwood, John David, Yanna Ko, Aviv Pudipeddi, Viraj Kariyawasam, Sudarshan Paramsothy, and Rupert W. Leong. 2024. “Biological Agents in the Treatment of Crohn’s Disease: A Propensity Score-Matched Analysis From the Prospective Persistence Australian National IBD Cohort (PANIC3) Study.” American Journal of Gastroenterology (Lippincott Williams & Wilkins) 119 (8): 1536–44. doi:10.14309/ajg.0000000000002679.